Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Finished Dosage Form (FDF) export of Tox21_300124 obtained from Indian Custom Trade Statistics

    Client Email Product

    Tox21_300124

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    12
    US DMFs Filed

    US DMFs Filed

    2
    CEP/COS Certifications

    CEP/COS Certifications

    1
    JDMFs Filed

    JDMFs Filed

    4
    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    6
    API REF. PRICE (USD / KG)
    3

    API Market Place

    27
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    9
    Europe

    Europe

    11
    Canada

    Canada

    50
    Australia

    Australia

    1
    South Africa

    South Africa

    7
    Uploaded Dossiers

    Uploaded Dossiers

    1
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    25.00

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS
    232
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    9

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    20
    REF STANDARD

    EDQM

    1

    USP

    4

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    left grey arrow
    right gray arrow
    • SOLUTION;IRRIGATION - 6.602GM/100ML;198MG/100ML;3.177GM/100ML
    • FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT
    left grey arrow
    right gray arrow
    refreshReset Filter
    product-page Product Main Page
    Ask UsAsk Us
    full-view Full Screen View

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    RAW MATERIAL-CITRIC ACID (B.NO.M603766 M FG.DT.03/2016 EXP.DT.03/2018

    Supporting Information : Click here to upload a PDF

    100
    1.2
    75.6
    08-Oct-2016
    115.4
    7,555.4
    Madras Sea
    30033900
    1531996

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    RAW MATERIAL-CITRIC ACID (B.NO.M603766 M FG.DT.03/2016 EXP.DT.03/2018

    Supporting Information : Click here to upload a PDF

    100
    1.2
    75.6
    08-Oct-2016
    115.4
    7,555.4
    Madras Sea
    30033900
    1532327

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACID MONOHYDRATE IP

    Supporting Information : Click here to upload a PDF

    100
    80
    80
    28-Sep-2016
    8,000
    8,000
    Raxaul
    30033900
    1318531

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICALS RAW MATERIAL CITRIC ACID MONO

    Supporting Information : Click here to upload a PDF

    100
    90
    91.9
    07-Sep-2016
    9,000
    9,192.3
    Raxaul
    30033900
    9915611

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    CITRIC ACID MONOHYDRATE USP

    Supporting Information : Click here to upload a PDF

    100
    2
    132.4
    07-Sep-2016
    200
    13,239.9
    Sabarmati ICD
    30049099
    9916927

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL.CITRIC ACID

    Supporting Information : Click here to upload a PDF

    25
    82
    82
    12-Aug-2016
    2,050
    2,050
    Raxaul (INRXLB)
    30033900
    9417977

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACID

    Supporting Information : Click here to upload a PDF

    125
    105
    107.2
    04-Aug-2016
    13,125
    13,396.4
    Raxaul (INRXLB)
    30033900
    9257780

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACID

    Supporting Information : Click here to upload a PDF

    50
    1.1
    75.7
    15-Jul-2016
    57
    3,786
    Raxaul (INRXLB)
    30033900
    8869591

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDANHYDROUS

    Supporting Information : Click here to upload a PDF

    25
    1.6
    106.1
    14-Jul-2016
    40
    2,652
    Raxaul (INRXLB)
    30033900
    8844077

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDMONOHYDRATE IP

    Supporting Information : Click here to upload a PDF

    300
    80
    80
    26-Jun-2016
    24,000
    24,000
    Raxaul (INRXLB)
    30033900
    8499541

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDMONOHYDRATE IP

    Supporting Information : Click here to upload a PDF

    75
    82
    82
    05-Jun-2016
    6,150
    6,150
    Raxaul (INRXLB)
    30033900
    8089449

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDANHYDROUSE IP

    Supporting Information : Click here to upload a PDF

    25
    98
    105.1
    30-May-2016
    2,450
    2,626.8
    Raxaul (INRXLB)
    30033900
    7944259

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDMONO IP

    Supporting Information : Click here to upload a PDF

    50
    80
    81.5
    23-May-2016
    4,000
    4,077.4
    Raxaul (INRXLB)
    30033900
    7812121

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDANHYDROUS IP

    Supporting Information : Click here to upload a PDF

    25
    110
    117.4
    03-May-2016
    2,750
    2,935.3
    Raxaul (INRXLB)
    30033900
    7430610

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    CITRIC ACID ANHYDROUS

    Supporting Information : Click here to upload a PDF

    2
    0.1
    3.3
    26-Apr-2016
    0.1
    6.6
    Hyderabad ACC (INHYD4)
    30041090
    7292155

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDMONO IP

    Supporting Information : Click here to upload a PDF

    100
    90
    91.1
    10-Apr-2016
    9,000
    9,105
    Raxaul (INRXLB)
    30033900
    6977801

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDANHYDROUS IP

    Supporting Information : Click here to upload a PDF

    25
    95
    95.3
    05-Apr-2016
    2,375
    2,382.2
    Raxaul (INRXLB)
    30033900
    6893171

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDMONO IP

    Supporting Information : Click here to upload a PDF

    200
    80
    81.6
    04-Apr-2016
    16,000
    16,329.7
    Raxaul (INRXLB)
    30033900
    6871314

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDMONOHYDRATE

    Supporting Information : Click here to upload a PDF

    200
    80
    81.8
    27-Mar-2016
    16,000
    16,350
    Raxaul
    30033900
    6695609

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIALCITRIC ACID MONO IP

    Supporting Information : Click here to upload a PDF

    25
    85
    86.4
    18-Mar-2016
    2,125
    2,160.3
    Raxaul
    30033900
    6532202

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    PHARMACEUTICAL RAW MATERIAL CITRIC ACIDMONO IP

    Supporting Information : Click here to upload a PDF

    100
    80
    81.1
    15-Mar-2016
    8,000
    8,105.4
    Raxaul
    30033900
    6471803
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    View Presentation

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search